Sequoia Financial Advisors LLC Boosts Holdings in Align Technology, Inc. $ALGN

Sequoia Financial Advisors LLC raised its position in Align Technology, Inc. (NASDAQ:ALGN) by 153.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,433 shares of the medical equipment provider’s stock after purchasing an additional 2,077 shares during the period. Sequoia Financial Advisors LLC’s holdings in Align Technology were worth $650,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Align Technology by 44.3% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 9,380 shares of the medical equipment provider’s stock valued at $1,490,000 after acquiring an additional 2,881 shares in the last quarter. Janney Montgomery Scott LLC raised its stake in Align Technology by 48.9% in the first quarter. Janney Montgomery Scott LLC now owns 10,120 shares of the medical equipment provider’s stock valued at $1,608,000 after purchasing an additional 3,325 shares in the last quarter. State of Alaska Department of Revenue raised its stake in Align Technology by 2.7% in the first quarter. State of Alaska Department of Revenue now owns 8,220 shares of the medical equipment provider’s stock valued at $1,305,000 after purchasing an additional 215 shares in the last quarter. Praxis Investment Management Inc. bought a new stake in Align Technology during the first quarter valued at approximately $249,000. Finally, Center for Financial Planning Inc. purchased a new position in Align Technology in the 1st quarter worth approximately $35,000. Institutional investors own 88.43% of the company’s stock.

Align Technology Price Performance

Shares of NASDAQ ALGN opened at $130.45 on Monday. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $246.19. The stock has a market capitalization of $9.46 billion, a P/E ratio of 22.00, a P/E/G ratio of 1.48 and a beta of 1.70. The company’s 50-day moving average is $134.71 and its 200 day moving average is $163.36.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the previous year, the firm posted $2.41 earnings per share. The business’s revenue was down 1.6% compared to the same quarter last year. Align Technology has set its Q3 2025 guidance at EPS. Research analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology announced that its board has authorized a share buyback program on Tuesday, August 5th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on ALGN shares. Morgan Stanley restated an “equal weight” rating and set a $154.00 price target (down previously from $249.00) on shares of Align Technology in a research report on Thursday, July 31st. Stifel Nicolaus dropped their price objective on Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a research note on Thursday, July 31st. Leerink Partners lowered their price objective on shares of Align Technology from $188.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, October 14th. Weiss Ratings cut Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, October 8th. Finally, Piper Sandler lowered their price target on Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $182.67.

Insiders Place Their Bets

In other news, CEO Joseph M. Hogan acquired 7,576 shares of the firm’s stock in a transaction on Friday, August 1st. The stock was acquired at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the acquisition, the chief executive officer owned 184,945 shares in the company, valued at $24,318,418.05. This trade represents a 4.27% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.66% of the stock is currently owned by insiders.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.